课题基金 / 基金详情

Development of highly efficient, selective, and practical synthetic method of pseudo-peptides possessing anti-tumour activity.

Development of highly efficient, selective, and practical synthetic method of pseudo-peptides possessing anti-tumour activity.
开发高效、选择性、实用的抗肿瘤活性伪肽合成方法。
批准号:
09557179
负责人:
FUJII Nobutaka
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

FUJII Nobutaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.We found a convenient method for the transformation of undesired anti-amino alcohols into desired cis-2-vinylaziridines, which are key synthetic intermediates for biologically active(E)-alkene peptide-isosteres, via trans-2-vinylaziridines by Pd(0)-catalyzed equilibration reaction.2.Various cis-aziridine derivatives were efficiently synthesized from 4-alkyl-5-vinyloxazilidin-2-ones and β-aziridinyl-α, β-unsaturated esters by the Pd(0)-mediated equilibration reaction.3.The ab initio calculations revealed that cis-β-aziridinyl-α, β-unsaturated esters, possessing cis-(E)-configuration, are more stable than their diastereoisomers. These results are compatible with the experimental results.4.In combination with Pd(0)-mediated isomerization and the regio- and stereo-specific SN2-type ring-opening reactions of β-aziridinyl-α,β-unsaturated esters with Brφnsted acids, the completely stereocontrolled synthetic process for(L,L)-, (L,D)-, (D,D)-, and (D,L)-type(E)-alkene dipeptide isosteres starting from amino acids has been established.5.Various peptide-isosteres containing Trp-, Asp-, Cys-, and Glu-analogues were synthesized by the reductive alkylation with organocopper reagents or by the nucleophilic alkylation with zinc-copper mixed reagents.6.Several bombesin analogues with(E)-alkene bond were prepared by replacing a constituent amino acid of bombesin with the synthesized peptide-isosteres, and these compounds were revealed to be potent bombesin receptor antagonists.
期刊论文(123)
专著(0)
科研奖励(0)
会议论文
M.Anzai et al.: "Palladium-catalyzed regio-and stereoselective synthesis of N-protected 2,4-dialkylated azacyclobutanes from amino allenes."Tetrahedron Letters. 40. 7393-7397 (1999)
M.Anzai 等人:“钯催化从氨基丙二烯区域选择性和立体选择性合成 N-保护的 2,4-二烷基化氮杂环丁烷。”四面体快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Takemoto et al.: "CAN-indced double ether formation : Synthesis of trans-and cis-fused tricyclic ethers from 3-oxabicyclo[3.1.0] hexyl sulfides."Chem.Commun. 2515-2516 (1999)
Y.Takemoto 等人:“CAN 诱导的双醚形成:从 3-氧杂双环[3.1.0]己基硫醚合成反式和顺式稠合三环醚。”Chem.Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Tamamura et al.: "Pharmacophore Identification of a Chemokine Receptor (CXCR4) Antagonist, T22(「Tvr5,12,Lvs7」-Polvphemusin II), which Specifically Blocks T Cell-Line-"Bioorg. Med. Chem.. 6. 1033-1041 (1998)
H. Tamamura 等人:“趋化因子受体 (CXCR4) 拮抗剂 T22(“Tvr5,12,Lvs7”-Polvphemusin II)的药效团鉴定,它特异性阻断 T 细胞系 -”Bioorg Med. 6。 .1033-1041 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Ohno et al.: "Palladium-catalyzed Reductive ring Opening with Formic Acid of Aziridines Bearing an α,β-Unsaturated Ester Group"Tetrahedron. 53. 12933-12946 (1997)
H.Ohno 等人:“带有 α,β-不饱和酯基团的氮丙啶的甲酸催化的还原开环”四面体。 53. 12933-12946 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
106
    Development and application of a novel screening technolgy toward effective uses of chemical library
    • 批准号:
      24659046
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Practical medicinal chemistry on the basis of protein chemistry, computational science and synthetic technologies for a variety of heterocycles
    • 批准号:
      23390025
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2011
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Evolution of Drug Discovery Targeting for G-protein Coupled Receptors
    • 批准号:
      17209004
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $33.36万
    • 财政年份:
      2005
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    Genome/Proteome-lead Drug Discovery Based on Peptide/Protein Chemistry
    • 批准号:
      14207099
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.28万
    • 财政年份:
      2002
    • 负责人:
      FUJII Nobutaka
    • 依托单位:
    海外基金